Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment

Antimicrob Agents Chemother. 2010 Sep;54(9):4038-40. doi: 10.1128/AAC.00533-10. Epub 2010 Jun 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Daptomycin / therapeutic use*
  • Humans
  • Linezolid
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / pathogenicity*
  • Microbial Sensitivity Tests
  • Middle Aged
  • Oxacillin / therapeutic use*
  • Oxazolidinones / therapeutic use
  • Teicoplanin / therapeutic use
  • Vancomycin Resistance

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Teicoplanin
  • Linezolid
  • Daptomycin
  • Oxacillin